Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 619.72 million compared to CNY 491.06 million a year ago. Revenue was CNY 619.72 million compared to CNY 491.06 million a year ago. Net income was CNY 274.59 million compared to CNY 229.13 million a year ago. Basic earnings per share from continuing operations was CNY 0.5244 compared to CNY 0.4376 a year ago. Diluted earnings per share from continuing operations was CNY 0.5244 compared to CNY 0.4376 a year ago.